Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 2 48-2, 2003, Pages

  Sippel, Rebecca S ^a   Carpenter, Jennifer E ^a   Kunnimalaiyaan, Muthusamy ^a   Lagerholm, Sara ^a   Chen, Herbert ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

MAP kinase; Neuroendocrine tumors; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHROMOGRANIN A; ESTROGEN; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RAF PROTEIN; SEROTONIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOID; CONTROLLED STUDY; DISEASE MARKER; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GASTROINTESTINAL TUMOR; HORMONE RELEASE; HUMAN; HUMAN CELL; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; SECRETORY GRANULE; SEROTONIN RELEASE; SIGNAL TRANSDUCTION;

EID: 0038442134     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00420.2002     Document Type: Article

References (38)

1. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, and Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
2. Baumann B, Weber CK, Troppmair J, Whiteside S, Israel A, Rapp UR, and Wirth T. Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci USA 97: 4615-4620, 2000.
3. Beauchamp RD, Coffey RJ Jr, Lyons RM, Perkett EA, Townsend CM Jr, and Moses HL. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth. Cancer Res 51: 5253-5260, 1991.
4. Bold RJ, Ishizuka J, Rajaraman S, Perez-Polo JR, Townsend CM Jr, and Thompson JC. Nerve growth factor as a mitogen for a pancreatic carcinoid cell line. J Neurochem 64: 2622-2628, 1995.
5. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, and Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
6. Bosch E, Cherwinski H, Peterson D, and McMahon M. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 15: 1021-1033, 1997.
7. Carson-Walter EB, Smith DP, Ponder BA, Baylin SB, and Nelkin BD. Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells. Oncogene 17: 367-376, 1998.
8. Carson EB, McMahon M, Baylin SB, and Nelkin BD. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation. Cancer Res 55: 2048-2052, 1995.
9. Chen H, Boyle TJ, Malim MH, Cullen BR, and Lyerly HK. Derivation of a biologically contained replication system for human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89: 7678-7682, 1992.
10. Chen H, Carson-Walter EB, Baylin SB, Nelkin BD, and Ball DW. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1. Surgery 120: 168-172, 1996.
11. Chen H, Hardacre JM, Uzar A, Cameron JL, and Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187: 88-92, 1998.
12. Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, Baylin SB, and Ball DW. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci USA 94: 5355-5360, 1997.
13. Chen J, Fujii K, Zhang L, Roberts T, and Fu H. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA 98: 7783-7788, 2001.
14. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD, and DePinho RA. Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472, 1999.
15. Creutzfeldt W. Carcinoid tumors: development of our knowledge. World J Surg 20: 126-131, 1996.
16. Evers BM, Townsend CM Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, Rajaraman S, Singh P, Reubi JC, and Thompson JC. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101: 303-311, 1991.
17. Hayne C, Tzivion G, and Luo ZJ. Raf-1/MEK/MAPK pathway is necessary for the G(2)/M transition induced by nocodazole. J Biol Chem 275: 31876-31882, 2000.
18. Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S, Sun XM, Brown J, Marais R, and Pritchard C. MEK kinase activity is not necessary for Raf-1 function. EMBO J 20: 1940-1951, 2001.
19. Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F, and Raybould HE. D-Glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 121: 1400-1406, 2001.
20. Kim M, Javed NH, Yu JG, Christofi F, and Cooke HJ. Mechanical stimulation activates Galphaq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cells. J Clin Invest 108: 1051-1059, 2001.
21. Lauffer JM, Zhang T, and Modlin IM. Review article: current status of gastrointestinal carcinoids. Aliment Pharmacol Ther 13: 271-287, 1999.
22. Miller CA and Ellison EC. Therapeutic alternatives in metastatic neuroendocrine tumors. Surg Oncol Clin N Am 7: 863-879, 1998.
23. Modlin IM and Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 79: 813-829, 1997.
24. Navas TA, Baldwin DT, and Stewart TA. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase. J Biol Chem 274: 33684-33690, 1999.
25. Paraskevakou H, Saetta A, Skandalis K, Tseleni S, Athanassiadis A, and Davaris PS. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids. Pathol Oncol Res 5: 205-210, 1999.
26. Parekh D, Ishizuka J, Townsend CM Jr, Haber B, Beauchamp RD, Karp G, Kim SW, Rajaraman S, Greeley G Jr, and Thompson JC. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 9: 83-90, 1994.
27. Ravi RK, Thiagalingam A, Weber E, McMahon M, Nelkin BD, and Mabry M. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol 20: 543-549, 1999.
28. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, Nelkin BD, and Mabry M. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 101: 153-159, 1998.
29. Rose DW, Xiao S, Pillay TS, Kolch W, and Olefsky JM. Prolonged vs. transient roles for early cell cycle signaling components. Oncogene 17: 889-899, 1998.
30. Schmied BM, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Weide L, Moyer MP, Batra SK, Adrian TE, and Pour PM. Transdifferentiation of human islet cells in a long-term culture. Pancreas 23: 157-171, 2001.
31. Sippel RS and Chen H. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery 132: 1035-1039, 2002.
32. Sumi S, Evers BM, Townsend CM Jr, Yoshinaga K, Uchida T, Murakami M, Sato K, Ishizuka J, and Thompson JC. Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2. Surg Oncol 2: 267-272, 1993.
33. Von Wichert G, Jehle PM, Hoeflich A, Koschnick S, Dralle H, Wolf E, Wiedenmann B, Boehm BO, Adler G, and Seufferlein T. Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res 60: 4573-4581, 2000.
34. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, and McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17: 5598-5611, 1997.
35. Wulbrand U, Remmert G, Zofel P, Wied M, Arnold R, and Fehmann HC. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours. Eur J Clin Invest 30: 729-739, 2000.
36. Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus F, Ito K, Aiyoshi Y, and Kaplan EL. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114: 758-763, 1993.
37. Younes N, Fulton N, Tanaka R, Wayne J, Straus FH, and Kaplan EL. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79: 1804-1808, 1997.
38. Zhang T, Townsend CM Jr, Udupi V, Yanaihara N, Rajaraman S, Beauchamp RD, Ishizuka J, Evers BM, Gomez G, Thompson JC, and Greeley GH Jr. Phorbol ester-induced alteration in the pattern of secretion and storage of chromogranin A and neurotensin in a human pancreatic carcinoid cell line. Endocrinology 136: 2252-2261, 1995.